[CLSTR]
< Back to situation

[REVISION HISTORY]

Heidi Overton FDA commissioner nomination hearing

Updated 9 times since CLSTR started tracking revisions of this situation.

What changed

2026-09-25 02:45 UTC → 2026-09-28 00:47 UTC · added removed

President Donald Trump has nominated Dr. Heidi Overton, a physician and White House domestic policy aide, to serve as the commissioner of the Food and Drug Administration (FDA). Overton would succeed Marty Makary, who resigned in May. During her Senate Health, Education, Labor and Pensions Committee confirmation hearing, Overton faced intense scrutiny regarding her policy positions. While she affirmed She testified that every vaccine all vaccines currently on the U.S. market is are ‘safe and effective,’ specifically endorsing the measles, mumps, and rubella (MMR) vaccine, she did not directly refute vaccine. She described the MMR vaccine as a ‘vital tool’ for managing ongoing measles outbreaks in the United States, a stance that diverges from President Trump’s claims characterizing characterization of the MMR vaccine as ‘quite lethal.’ Lawmakers, including Senator Bill Cassidy, Lawmakers continued to press her on her previous support for altering childhood vaccination schedules. Regarding reproductive health, Overton stated that the abortion pill mifepristone has met FDA safety and efficacy standards. This testimony follows pressure from a coalition of 50 pro-life leaders, including Liberty Counsel, who urged her leaders to restore in-person dispensing requirements requirements. It also drew criticism from Senate Democrats regarding a 2023 article Overton wrote in which she characterized chemical abortion as ‘dangerous to replace current telehealth and mail-order options. women.’ Overton also discussed potential regulatory changes regarding flavored electronic cigarettes and reiterated her commitment to increasing agency efficiency to compete with China’s biotechnology industry through initiatives like ‘Operation Trailblazer.’ If confirmed, she will lead an agency that has seen its workforce reduced from 18,200 to approximately 16,000 following Department of Government Efficiency (DOGE) cuts, tasked with advancing the ‘Make America Healthy Again’ movement.

Versions

  1. 2026-09-28 00:47 UTC Heidi Overton FDA commissioner nomination hearing
  2. 2026-09-25 02:45 UTC Heidi Overton FDA commissioner nomination hearing
  3. 2026-09-24 21:22 UTC Heidi Overton FDA commissioner nomination hearing
  4. 2026-09-24 16:07 UTC Heidi Overton FDA commissioner nomination
  5. 2026-09-24 02:46 UTC Heidi Overton FDA commissioner nomination
  6. 2026-09-22 19:14 UTC Heidi Overton FDA commissioner nomination
  7. 2026-09-01 17:53 UTC Heidi Overton FDA commissioner nomination
  8. 2026-08-26 21:17 UTC Heidi Overton FDA commissioner nomination
  9. 2026-08-26 00:37 UTC Heidi Overton FDA commissioner nomination
  10. 2026-08-22 03:38 UTC Heidi Overton FDA commissioner nomination

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.